This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Verily Life Sciences LLC. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Dave Steiner in Prostate Biopsy Analysis
Introduction
Dave Steiner is an accomplished inventor based in Mountain View, CA. He has made significant contributions to the field of medical technology, particularly in the analysis of prostate biopsies. His innovative work focuses on enhancing the accuracy and efficiency of biopsy reviews through artificial intelligence.
Latest Patents
Dave Steiner holds a patent for an "Artificial intelligence-based assistant for concurrent review of needle core prostate biopsies." This invention involves a method that includes receiving a digital image of a needle core prostate biopsy and displaying a magnified portion of that image. The process utilizes a deep learning model to obtain Gleason scores for various patches of the image. The results are then displayed with a superimposed overlay that highlights the Gleason scores and their corresponding confidence values, providing a visual representation that aids in the diagnostic process.
Career Highlights
Throughout his career, Dave has been dedicated to advancing medical technology. His work at Verily Life Sciences LLC has positioned him at the forefront of innovation in healthcare. He has successfully developed tools that leverage artificial intelligence to improve clinical outcomes for patients undergoing prostate biopsies.
Collaborations
Dave collaborates with talented professionals in his field, including Craig Mermel and Cameron Chen. Their combined expertise fosters an environment of innovation and progress within the company.
Conclusion
Dave Steiner's contributions to the field of prostate biopsy analysis through his patented technology exemplify the impact of innovation in healthcare. His work not only enhances diagnostic accuracy but also represents a significant advancement in the use of artificial intelligence in medicine.
